OACCU NASDAQ
Oaktree Acquisition Corp. III Life Sciences Unit
1W: -0.6%
1M: -0.6%
3M: -0.6%
YTD: +2.0%
1Y: +2.6%
$10.93
-0.07 (-0.64%)
Weekly Expected Move ±0.3%
$11
$11
$11
$11
$11
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$262.4M
52W Range10.46-12.47
Volume1
Avg Volume198
Beta-0.03
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOZaid Pardesi
Employees3
SectorFinancial Services
IndustryShell Companies
IPO Date2024-10-24
333 South Grand Avenue
Los Angeles, CA 90071
US
Los Angeles, CA 90071
US
+1 213 830 6300
About Oaktree Acquisition Corp. III Life Sciences Unit
Oaktree Acquisition Corp. III Life Sciences operates as a special purpose acquisition company (SPAC). Its primary objective is to execute a strategic business combinationâsuch as a merger, an exchange of capital stock, an asset or stock acquisition, or a broader corporate restructuringâwith one or more existing enterprises. Established in 1995, this company maintains its principal office in Los Angeles, California.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Martinez George Arth | 0 | — | 2025-10-29 | |
| BERRY DAVID A | 0 | — | 2025-10-17 | |
| Sweeney Thomas | 0 | — | 2025-06-03 | |
| Oaktree Acquisition | J-Other | 231,492 | — | 2024-10-30 |
| Oaktree Acquisition | C-Conversion | 33,981 | $10.00 | 2024-10-30 |